This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
FRANKLIN LAKES, N.J.,
March 1, 2012 /PRNewswire/ -- For the fifth consecutive year, Medco Health Solutions, Inc. (NYSE: MHS) has captured the No. 1 position within the Health Care: Pharmacy and Other Services sector on
Fortune's "World's Most Admired Companies" list. Medco earned the highest ranking across five of nine attributes within that sector: innovation, people management, social responsibility, quality of management, quality of products/services. It earned the second highest ranking for the attributes: use of corporate assets, financial soundness, long-term investment and global competitiveness.
Medco is also ranked second among the most admired companies in
Fortune World's Most Admired Companies list is a report card on corporate reputation. In partnership with the Hay Group, Fortune surveyed more than 698 companies across 58 industries and 32 countries. To establish the rankings, executives, directors, and securities analysts were asked to rate companies in their own industry on nine criteria, from investment value to social responsibility. Results will be featured in the
March 5 issue of
"Medco employees are among the best and brightest in the healthcare industry, and their dedication to innovation and service have kept Medco a
Most Admired company for 5 consecutive years," said Medco Chairman and CEO
David B. Snow Jr. "To continue to earn this No. 1 position in our competitive sector demonstrates that Medco's business model and commitment to making medicine smarter is delivering value for our members, clients and shareholders."
About MedcoMedco Health Solutions, Inc. (NYSE: MHS) is pioneering the
world's most advanced pharmacy® and its clinical research and innovations are part of
Medco making medicine smarter™ for approximately millions of Americans.
With more than 20,000 employees worldwide dedicated to improving patient health and reducing costs for a wide range of public and private sector clients, and 2011 revenue of
$70 billion, Medco ranks 34th on the 2011
Fortune 500 list and is named among the world's most innovative, most admired and most trustworthy companies.
For more information, go to
This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the risks and uncertainties that affect our business, particularly those mentioned in the Risk Factors section of the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission.